Literature DB >> 17420208

SME-2-producing Serratia marcescens isolate from Switzerland.

Laurent Poirel, Aline Wenger, Jacques Bille, Sandrine Bernabeu, Thierry Naas, Patrice Nordmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17420208      PMCID： PMC1891368          DOI： 10.1128/AAC.00309-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

Review 1.  Emerging carbapenemases in Gram-negative aerobes.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2002-06       Impact factor: 8.067

2.  SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases.

Authors:  Anne Marie Queenan; Wenchi Shang; Paul Schreckenberger; Karen Lolans; Karen Bush; John Quinn
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

3.  rpoB sequence analysis as a novel basis for bacterial identification.

Authors:  C Mollet; M Drancourt; D Raoult
Journal:  Mol Microbiol       Date:  1997-12       Impact factor: 3.501

4.  Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme.

Authors:  A C Gales; D J Biedenbach; P Winokur; D M Hacek; M A Pfaller; R N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2001-02       Impact factor: 2.803

5.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

Review 6.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  SME-type carbapenem-hydrolyzing class A beta-lactamases from geographically diverse Serratia marcescens strains.

Authors:  A M Queenan; C Torres-Viera; H S Gold; Y Carmeli; G M Eliopoulos; R C Moellering; J P Quinn; J Hindler; A A Medeiros; K Bush
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

8.  Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A beta-lactamase, Sme-1, from Serratia marcescens S6.

Authors:  T Naas; L Vandel; W Sougakoff; D M Livermore; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

9.  Characterization of an LysR family protein, SmeR from Serratia marcescens S6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase Sme-1, and comparison of this regulator with other beta-lactamase regulators.

Authors:  T Naas; D M Livermore; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae.

Authors:  Laurent Poirel; Claire Héritier; Venus Tolün; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191
  10 in total
  7 in total

1.  Epidemiology of carbapenem resistant Enterobacteriaceae (CRE) during 2000-2012 in Asia.

Authors:  Yanling Xu; Bing Gu; Mao Huang; Haiyan Liu; Ting Xu; Wenying Xia; Tong Wang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  Genetic and Biochemical Characterization of FRI-1, a Carbapenem-Hydrolyzing Class A β-Lactamase from Enterobacter cloacae.

Authors:  Laurent Dortet; Laurent Poirel; Samia Abbas; Saoussen Oueslati; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

3.  Activity of Imipenem-Relebactam and Meropenem-Vaborbactam against Carbapenem-Resistant, SME-Producing Serratia marcescens.

Authors:  M Biagi; A Shajee; A Vialichka; M Jurkovic; X Tan; E Wenzler
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

4.  Inhibition of class A beta-lactamases by carbapenems: crystallographic observation of two conformations of meropenem in SHV-1.

Authors:  Michiyosi Nukaga; Christopher R Bethel; Jodi M Thomson; Andrea M Hujer; Anne Distler; Vernon E Anderson; James R Knox; Robert A Bonomo
Journal:  J Am Chem Soc       Date:  2008-08-30       Impact factor: 15.419

Review 5.  Structural and Functional Aspects of Class A Carbapenemases.

Authors:  Thierry Naas; Laurent Dortet; Bogdan I Iorga
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 6.  Genetic Diversity, Biochemical Properties, and Detection Methods of Minor Carbapenemases in Enterobacterales.

Authors:  Rémy A Bonnin; Agnès B Jousset; Cécile Emeraud; Saoussen Oueslati; Laurent Dortet; Thierry Naas
Journal:  Front Med (Lausanne)       Date:  2021-01-20

7.  "Stormy waters ahead": global emergence of carbapenemases.

Authors:  Gopi Patel; Robert A Bonomo
Journal:  Front Microbiol       Date:  2013-03-14       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.